Lv62
2970 积分 2023-06-12 加入
763-P: Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Dual GLP-1/GIP Receptor Agonist (HRS9531) in Healthy Subjects—A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose (SAD and MAD) Study
3个月前
已关闭
Asundexian versus Apixaban in Patients with Atrial Fibrillation
4个月前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
4个月前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
4个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
4个月前
已完结
胰高糖素样肽‐1 受体激动剂类药物结合生活方式干预减重专家共识（2024 版）
6个月前
已完结
NEJM at ESC — Asundexian versus Apixaban in Patients with Atrial Fibrillation
6个月前
已关闭
Asundexian versus Apixaban in Patients with Atrial Fibrillation
6个月前
已完结
肥胖患者的长期体重管理及药物临床应用指南(2024版)
7个月前
已完结
Changes in Gastric Inhibitory Polypeptide (GIP) After Roux-en-Y Gastric Bypass in Obese Patients: a Meta-analysis
8个月前
已完结
Macro-microporous zeolitic imidazole framework-8/cellulose aerogel for semi-automated pipette tip solid phase extraction of fluoroquinolones in water
1年前
已驳回
Macro-microporous zeolitic imidazole framework-8/cellulose aerogel for semi-automated pipette tip solid phase extraction of fluoroquinolones in water
1年前
已驳回
皖公网安备34019202002308
